Are Reliv products patented?

24K™, ProVantage®, GlucAffect®, Arthaffect®, ReversAge®, and FibRestore® are currently under U.S. patents. The first Reliv Classic® patent was issued in 1988 and has since expired, as has the Innergize!® patent issued in 1994. In order for an invention to be patented, the U.S. patent laws provide that it must (A) have utility and (B) be novel and non-obvious over the prior art. The U.S. Patent Office substantively examines patent applications to ensure that patents are issued only for inventions that satisfy these legal criteria.
Reliv also holds two lunasin-related patents:

1. A patent on lunasin’s mechanism of action for reducing LDL cholesterol in the body.
2. A composition of matter patent on Reliv’s LunaRich technology as it relates to its superior ability to deliver bioactive lunasin to the body.